Bolt Biotherapeutics (BOLT) Return on Equity (2020 - 2025)
Historic Return on Equity for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to 1.21%.
- Bolt Biotherapeutics' Return on Equity fell 3200.0% to 1.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.21%, marking a year-over-year decrease of 3200.0%. This contributed to the annual value of 0.8% for FY2024, which is 3100.0% down from last year.
- As of Q3 2025, Bolt Biotherapeutics' Return on Equity stood at 1.21%, which was down 3200.0% from 1.19% recorded in Q2 2025.
- In the past 5 years, Bolt Biotherapeutics' Return on Equity registered a high of 0.18% during Q2 2021, and its lowest value of 1.22% during Q1 2025.
- Moreover, its 5-year median value for Return on Equity was 0.51% (2023), whereas its average is 0.63%.
- In the last 5 years, Bolt Biotherapeutics' Return on Equity tumbled by -8300bps in 2021 and then changed by 0bps in 2022.
- Over the past 5 years, Bolt Biotherapeutics' Return on Equity (Quarter) stood at 0.28% in 2021, then tumbled by -73bps to 0.49% in 2022, then fell by -17bps to 0.57% in 2023, then plummeted by -83bps to 1.05% in 2024, then dropped by -15bps to 1.21% in 2025.
- Its Return on Equity stands at 1.21% for Q3 2025, versus 1.19% for Q2 2025 and 1.22% for Q1 2025.